If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 347.00
Bid: 346.00
Ask: 348.00
Change: 5.00 (1.46%)
Spread: 2.00 (0.578%)
Open: 330.00
High: 348.00
Low: 330.00
Prev. Close: 342.00
VLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full Year Trading Update

18 Apr 2023 07:00

RNS Number : 4982W
Volex PLC
18 April 2023
 

 

Volex plc

 

("Volex", the "Group", or the "Company")

 

Full Year Trading Update

 

Strong organic growth with revenue and profit ahead of expectations

 

Volex (AIM: VLX), the specialist integrated manufacturer of critical power and data transmission products, today issues an update on trading for the 52 weeks ended 2 April 2023 (the "Year" or "FY2023").

 

Full year trading ahead of market expectations

 

Volex has continued its positive momentum and demonstrated further progress during the Year, reflecting its compelling positions in attractive markets with strong structural growth characteristics.

 

Revenue is now expected to be at least $710 million, representing an increase of at least 15.5% compared with the prior year. Underlying operating profit is now expected to be at least $66 million, at least 17.4% higher than the prior year, with both revenue and underlying operating profit ahead of market expectations1, 2.

 

An increase in gross margins and continued cost control improvements is expected to deliver a strengthening in underlying operating margins to 9.3% (FY2022: 9.1%). The Group has delivered margins within its targeted range for three years, managing inflationary cost challenges and demonstrating the strong competitive positioning.

 

Operating free cash flow in the second half of the Year was substantially higher than the first half. After capital investment, dividend payments and acquisition consideration of approximately $46 million in the Year, pre-IFRS 16 net debt is expected to be approximately $76 million. This is a reduction of $22 million since the half year and represents a covenant leverage of 1.0x3, comfortably below the Group's target leverage corridor.

 

Continued outperformance of underlying markets provides strong momentum into FY2024

 

Against a volatile backdrop in FY2023, Volex delivered strong organic growth, ahead of its underlying markets, which has been driven by continued execution of the Group's commercial strategy which focuses on:

 

· Targeting structural growth markets - with the Electric Vehicles, Complex Industrial Technology and Medical sectors all delivering strong constant currency organic revenue growth in FY2023. Pleasingly, the adverse impact of post-pandemic demand normalisation in the Consumer Electricals sector is being largely offset by market share gains

 

· Leveraging the Group's global footprint - which is enabling the Group to benefit from heightened levels of demand in a number of territories as a result of customers re-configuring supply chains to focus on partners with high service levels and local facilities

 

· Expanding the Group's range of capabilities - through targeted investment the Group has continued to expand its offering which has led to a high level of new project wins with both new and existing customers

 

Volex is well positioned to continue investing in sustainable organic growth with a robust balance sheet and healthy cash generation. The Group has an active acquisition pipeline of value enhancing opportunities, which will support the achievement of the five-year strategy to grow revenues to $1.2 billion by the end of FY2027.

 

Nat Rothschild, Executive Chairman, said: "I am delighted with the strong organic growth performance delivered by the business during the period. We continue to deliver against the long-term, strategic growth plan that we unveiled last year and I firmly believe that Volex's diverse global footprint, ongoing investment plans and reputation for excellence will continue to drive ongoing outperformance versus our competitors. This, combined with our robust balance sheet and healthy cash generation, means that the Group is well positioned as we enter the new financial year."

 

-ENDS-

 

 

For further information please contact:

Volex plc

Nat Rothschild, Executive Chairman

Jon Boaden, Chief Financial Officer

+44 (0)7747 488785

investor.relations@volex.com

 

Singer Capital Markets - Nominated Adviser & Joint Broker

Shaun Dobson

George Tzimas

+44 (0)20 7496 3000

 

HSBC Bank plc - Joint Broker

Simon Alexander

Joe Weaving

+44 (0)20 7991 8888

 

Powerscourt - Media Enquiries

James White

Nicholas Johnson 

 

+44 (0)20 7250 1446

 

Notes:

1. Underlying operating profit is before adjusting items which are one-off in nature and significant (such as restructuring costs, impairment charges or acquisition-related costs), the amortisation and impairment of acquired intangible assets and share-based payment charges. This trading update is based upon unaudited management accounts information. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2. The Company has compiled forecasts from five analysts with current market forecasts for the 52 weeks ending 2 April 2023 for revenue to be in the range of $690.5 million to $695.0 million, with a consensus of $692.9 million, and for underlying operating profit to be in the range of $62.3 million to $64.0 million, with a consensus of $62.9 million.

 

3. Covenant leverage represents the ratio of net debt, excluding operating lease liabilities, to EBITDA excluding the impact of right of use amortisation arising on operating lease arrangements. This measure is aligned with the covenant calculations used for external debt facilities.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLDSDIDLIV
Date   Source Headline
29th Jul 20114:35 pmRNSPrice Monitoring Extension
25th Jul 20115:00 pmRNSVOTING RESULTS OF 2011 AGM
25th Jul 20113:53 pmRNSDirector/PDMR Shareholding
25th Jul 20117:00 amRNSInterim Management Statement
21st Jul 20117:00 amRNSAnnual Information Update
23rd Jun 20117:00 amRNSAnnual Report & Accounts & Notification of AGM
13th Jun 20112:26 pmRNSPreference Share Dividend
7th Jun 20112:14 pmRNSVolex announces dividend and record payment dates
1st Jun 20117:00 amRNSPreliminary Results
14th Apr 20117:00 amRNSTrading Update
17th Feb 20114:10 pmRNSDirector/PDMR Shareholding
16th Feb 20111:33 pmRNSInvestor Seminar
16th Feb 20117:00 amRNSInterim Management Statement
6th Jan 20117:00 amRNSAppointment of Non - Executive Director
13th Dec 201012:07 pmRNSNotification of Major Interest in Shares
8th Dec 20107:00 amRNSRelease of Special Reserve
7th Dec 20107:00 amRNSNew Ordinary Shares issued
22nd Nov 201012:22 pmRNSNotification of Major Interest in Shares
22nd Nov 20107:00 amRNSVoting Rights and Capital
2nd Nov 20107:00 amRNSHalf-yearly results
5th Oct 20107:00 amRNSNew Share Issuance
1st Oct 20103:15 pmRNSResult of GM
23rd Sep 20107:00 amRNSAppointment
16th Sep 20107:00 amRNSNotice of General Meeting
25th Aug 20102:10 pmRNSDirector PDMR Shareholding
2nd Aug 20107:00 amRNSAnnual Information Update
27th Jul 20107:00 amRNSInterim Management Statement
26th Jul 20102:02 pmRNSSpecial Resolutions Passed at AGM
14th Jul 201011:53 amRNSResult of AGM
5th Jul 201011:19 amRNSRule 9.6.14
25th Jun 20104:49 pmRNSNotification of Major Interest in Shares
21st Jun 20109:49 amRNSNotification Of Major Interest In Shares
17th Jun 201010:52 amRNSAnnual Report and Accounts & Notice of AGM
10th Jun 20104:29 pmRNSNotification Of Major Interests In Shares
1st Jun 20107:00 amRNSPreliminary Results
19th May 20101:36 pmRNSBlock Listing Six Monthly Return
19th May 20101:35 pmRNSBlock Listing Six Monthly Return
26th Apr 201010:35 amRNSNotification Of Major Interest In Shares
19th Apr 20107:00 amRNSTrading Update
7th Apr 201010:00 amRNSAppointment of joint broker
29th Mar 20109:40 amRNSDirector/PDMR Shareholding
22nd Mar 20104:38 pmRNSHolding(s) in Company
18th Mar 20101:00 pmRNSPartnership with Huawei
3rd Mar 201012:13 pmRNSHolding(s) in Company
9th Feb 20107:00 amRNSInterim Management Statement
1st Feb 201012:00 pmRNSAward Win
25th Jan 20103:00 pmRNSHolding(s) in Company
12th Jan 20107:00 amRNSTrading Statement
11th Jan 201012:10 pmRNSHolding(s) in Company
5th Jan 20107:00 amRNSAward Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.